A research group of the Veneto Institute of Molecular Medicine (VIMM) and of the University of Padua, coordinated by Prof. Renato Zambello by Prof. Gianpietro Semenzato and by the Department of Hematology and Clinical Immunology directed by Prof. Livio Trentin, recently published the results of a multicenter Italian study, carried out in collaboration with Prof. Stefania Bortoluzzi (Padua), Prof. Sara Galimberti (Pisa), and Prof. Enrico Tiacci (Perugia).
The first author of the article published in the prestigious journal Nature Communications is Dr. Antonella Teramo (VIMM and University of Padua). The data just published have allowed us to identify new markers useful for diagnostic analyzes and better care of patients with Tγδ-type large granulated lymphocyte leukemia (Tγδ Large Granular Lymphocyte leukemia, Tγδ LGLL).
“The novelty of this study concerns the identification of new markers to clearly distinguish the types of diseases from which patients are affected, thus providing doctors who are faced with cases of this little-known leukemia the strategy to apply and the characteristics that are crucial for recognizing the variant and sub-variants ”comments Dr. Teramo, head of the study.
Prof. Semenzato, Scientific Director of VIMM also underlines: “The study has brought to light interesting data that allow us to take a step forward in understanding the mechanisms that lead to the onset of this disease, the initial cause of which remains today. unknown “.